Harvard Bioscience (HBIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Sales | 116,176 | 120,774 | 77,407 | 104,521 | 108,664 |
| Cost of Goods | 51,854 | 57,593 | 38,237 | 56,106 | 59,941 |
| Gross Profit | 64,322 | 63,181 | 39,170 | 48,415 | 48,723 |
| Operating Expenses | 64,799 | 62,790 | 40,042 | 51,518 | 51,377 |
| Operating Income | 377 | 984 | -635 | -2,997 | -1,713 |
| Interest Expense | 5,410 | 5,367 | 713 | 639 | 846 |
| Other Income | -469 | -3,592 | -1,273 | 558 | -1,049 |
| Pre-tax Income | -5,502 | -7,975 | -2,621 | -3,078 | -3,608 |
| Income Tax | -815 | -3,676 | -605 | 1,229 | 15,431 |
| Net Income Continuous | -4,687 | -4,299 | -2,016 | -4,307 | -19,039 |
| Net Income Discontinuous | N/A | 1,377 | 1,151 | N/A | N/A |
| Net Income | $-4,687 | $-2,922 | $-865 | $-4,307 | $-19,039 |
| EPS Basic Total Ops | -0.12 | -0.08 | -0.02 | -0.13 | -0.57 |
| EPS Basic Continuous Ops | -0.12 | -0.12 | -0.06 | -0.13 | -0.57 |
| EPS Basic Discontinuous Ops | N/A | 0.04 | 0.03 | N/A | N/A |
| EPS Diluted Total Ops | -0.12 | -0.08 | -0.02 | -0.13 | -0.57 |
| EPS Diluted Continuous Ops | -0.12 | -0.12 | -0.06 | -0.13 | -0.57 |
| EPS Diluted Discontinuous Ops | N/A | 0.04 | 0.03 | N/A | N/A |
| EPS Diluted Before Non-Recurring Items | 0.12 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $8,495 | $9,483 | $3,210 | $1,368 | $2,946 |